Publications

Clinical Outcomes of Infections Caused by Extended-Spectrum &#223-Lactamase (ESBL)-Producing Bacteria with Reduced Carbapenem Susceptibility, Lead author: Le, presented at 49th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2009, San Francisco, CA

Correlation of Baseline Methicillin-Resistant Staphylococcus aureus (MRSA) Isolate Characteristics with Clinical Outcome from a Randomized Phase 4 Clinical Trial of Complicated Skin and Soft Tissue Infections, Lead author: Hogan, presented at 49th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2009, San Francisco, CA

Low Prevalence of fks1 Hotspot 1 Mutations in a Worldwide Collection of Candida spp., Lead author: Castanheira M, presented at 49th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2009, San Francisco, CA

Assessment of Non-Antibiotic Therapeutic Agent Interactions on the Potency of Orally Administered Vancomycin, Lead author: Sader HS, presented at 109th annual American Society for Microbiology General Meeting (ASM), May 17 – 21, 2009, Philadelphia, PA

Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) Program 2008 (Europe, Latin America, Canada, Asia Pacific): Linezolid Global In Vitro Susceptibility Analyses, Lead author: Ross JE, presented at 109th annual American Society for Microbiology General Meeting (ASM), May 17 – 21, 2009, Philadelphia, PA

Linezolid Experience and Accurate Determination of Resistance (LEADER) Program 2008: USA Surveillance Report, Lead author: Jones RN, presented at 109th annual American Society for Microbiology General Meeting (ASM), May 17 – 21, 2009, Philadelphia, PA

Escherichia coli Resistance to Fluoroquinolones at a Comprehensive Cancer Centre, Lead author: Mihu, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Genetic Evidence for KPC-encoding Resistance among Six Enterobacteriaceae Species other than K. pneumoniae, Lead author: Castanheira M, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

First description of KPC-2 in Raoultella planticola: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Castanheira M, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Acquisition of cfr Gene by an Epidemic Cluster of S. epidermidis Causing Bloodstream Infections in Hospitalized Patients from Rome, Italy, Lead author: Mendes RE, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Ceftaroline Activity Tested against Common Organisms Causing Skin and Skin-structure Infections in European Medical Centres During 2008, Lead author: Sader HS, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Antimicrobial Activity of Ceftaroline against Bacteria Isolated in 2008 from Community-acquired Respiratory Tract Infections in European Hospitals, Including Methicillin-resistant Staphylococcus aureus, Lead author: Sader HS, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Spectrum and Potency of Ceftobiprole Against Leading North American Pathogens Producing Community- and Hospital-Acquired Pneumonia (2005-2007), Lead author: Jones RN, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Antimicrobial Activity of Ceftobiprole, a Novel Anti-Methicillin Resistant S. aureus (MRSA) Cephalosporin, Tested Against Skin and Skin Structure Infection Pathogens (North America), Lead author: Jones RN, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Antimicrobial Characterization of CEM-101: Activity against Staphylococci, Beta-haemolytic and Viridans group streptococci, Lead author: Jones RN, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Activity of CEM-101 Tested Against Emerging Telithromycin-Resistant Beta-Haemolytic Streptococci (BHS), Lead author: Jones RN, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Novel PER-variant ß-lactamase identified in Providencia rettgeri strain from the United States (USA): Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Castanheira M, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Pharmacodynamically-linked Variable for the Combination of Ceftaroline plus Novexel104, Lead author: Drusano GL, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Update on the Spectrum and Potency of Tigecycline Tested against 7,133 Gram-positive and -negative Pathogens from 13 Countries (2008), Lead author: Biedenbach DJ, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Worldwide activity of Tigecycline against Community-acquired Respiratory Tract Infection Pathogens Collected During 2006-2008, Lead author: Biedenbach DJ, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Report of Linezolid Resistance from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) Program (Europe, Latin America, Asia Pacific), Lead author: Ross JE, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Update on daptomycin activity and spectrum when tested against Gram-positive strains collected in European medical centres (2007-2008), Lead author: Sader HS, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Potent Antimicrobial Activity of Daptomycin Tested against Staphylococcus aureus with Vancomycin MIC of 2 mg/L Isolated in United States and European hospitals (2006-2008), Lead author: Sader HS, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Prevalence of Extended-spectrum Beta-lactamases among Enterobacteriaceae Strains from the United States (USA; 2007) and Correlation with KPC Carbapenemases, Lead author: Castanheira M, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Prevalence and Antimicrobial Susceptibility Patterns of Methicillin-resistant S. aureus and Vancomycin-resistant E. faecium Causing Bloodstream Infections in European Hospitals (2005-2008), Lead author: Sader HS, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Telavancin Activity against S. aureus and Coagulase-negative Staphylococci Collected from Clinical Infections in Europe (2007-2008), Lead author: Rhomberg PR, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Antimicrobial Activity of Telavancin Tested against Streptococcal Species Isolates Collected from European Medical Centres (2007-2008), Lead author: Rhomberg PR, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Telavancin Antimicrobial Activity when Tested against Enterococci and Uncommonly Isolated Gram-positive Species (European Sample for 2007-2008), Lead author: Rhomberg PR, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Ten-year trend in aminoglycoside resistance from a worldwide collection of Gram-negative pathogens (1998-2007), Lead author: Biedenbach DJ, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Surveying Aminoglycoside Resistance Mechanisms: a Tool for the Development of Neoglycosides, Lead author: Armstrong, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Anti-pseudomonal Activity of Piperacillin/tazobactam: More than a Decade of Experience from the SENTRY Antimicrobial Surveillance Program (1997-2007), Lead author: Jones RN, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Detection of cfr-carrying Staphylococcus spp. Isolates Recovered from Blood Cultures in a Spanish Hospital During a Phase III Clinical Trial of Topical Omiganan 1% Gel Versus 10% Povidone Iodine, Lead author: Mendes RE, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Extended Studies of Piperacillin/tazobactam Generic Formulations: Variations of Branded Product Lots and Assessment of 38 Generic Lots, Lead author: Jones RN, presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 16 – 19, 2009, Helsinki, Finland

Antimicrobial Activity of the Novel Cephalosporin Ceftaroline Tested Against Gram-positive Organisms Causing Skin and Skin Structure Infections (SSSI) Isolated in USA and European Medical Centers in 2008, Lead author: Sader HS, presented at 29th annual Surgical Infection Society (SIS), May 5 – 8, 2009, Chicago, IL

Activity of Daptomycin (DAP) and Comparators Tested Against Gram-positive (GP) Organisms from Bacteremia, Lead author: Sader HS, presented at XIV annual Pan American Congress of Infectology, April 25 – 28, 2009, Sao Paulo, Brazil

Daptomycin Activity against Gram-positive Bacteria Causing Skin and Skin Structure Infections (SSSI), Lead author: Andrade SS, presented at XIV annual Pan American Congress of Infectology, April 25 – 28, 2009, Sao Paulo, Brazil

High prevalence of Macrolide-Lincosamide Resistance in Streptococcus agalactiae in the Asia-Pacific Region; a SENTRY Antimicrobial Surveillance Program Report, Lead author: Bell JM, presented at 7th annual International Symposium on Antimicrobial Agents and Resistance (ISAAR), March 18 – 20, 2009, Bangkok, Thailand

Prevelance of Mupirocin Resistance in Staphylococcus spp. In the Asia-Pacific Region (2004; 2006-2008); A SENTRY Antimicrobial Surveillance Program Report, Lead author: Bell JM, presented at 7th annual International Symposium on Antimicrobial Agents and Resistance (ISAAR), March 18 – 20, 2009, Bangkok, Thailand

Potency and bactericidal activity of iclaprim against Gram-positive isolates. by Sader HS, Fritsche TR and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (5): 2171-2175

In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens by Jones RN, Bell JM, Sader HS, Turnidge JD and Stilwell MG published in Diagn. Microbiol. Infect. Dis. 2009; 63 (4): 434-439

Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: Results from a global surveillance study (2003-2007). by Fritsche TR, Sader HS, Stillwell MG, Jones RN published in Diagn. Microbiol. Infect. Dis. 2009; 63 (4): 440-446

Antimicrobial activities of doripenem and other carbapenems against Pseudmonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp. by Castanheira M, Jones RN, Livermore DM published in Diagn. Microbiol. Infect. Dis. 2009; 63 (4): 426-433

Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents. by Mendes RE, Rhomberg PR, Bell JM, Turnidge JD, Sader HS published in Diagn. Microbiol. Infect. Dis. 2009; 63 (4): 415-425

Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients. by Sader HS, Fritsche TR, Jones RN published in Int. J. Infect. Dis. 2009; 13 (2): 291-295

In vitro activity of iclaprim and comparison agents tested against Neisseria gonorrhoeae including medium growth supplement effects. by Jones RN, Biedenbach DJ and Sader HS published in Diagn. Microbiol. Infect. Dis. 2009; 63 (3): 339-341

Carbapenem resistance among Pseudmonas aeruginosa strains form India: Evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18). by Castanheira M, Bell JM, Turnidge JD, Mathai D and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (3): 1225-1227

Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler’s diarrhea. by Fritsche TR, Biedenbach DJ and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (3): 1221-1224

Codetection of bla_OXA-23-like gene (bla_OXA-133) and bla_OXA-58 in Acintobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program. by Mendes RE, Bell JM, Turnidge JD, Castanheira M, Deshpande LM and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (2): 843-844

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. by Diekema DJ, Messer SA, Hollis RJ, Boyken L, Tendolkar S, Kroeger J, Jones RN and Pfaller MA published in Diagn. Microbiol. Infect. Dis. 2009; 233 (2): 233-236

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemased among Acinetobacter spp. in Asia-Pacific nations: Report from the SENTRY Surveillance Program. by Mendes RE, Bell JM, Turnidge JD, Castanheira M, and Jones RN published in J. Antimicrob. Chemother. 2009; 63 (1): 55-59